catecholamines 2 Flashcards
Small amount of drug that stimulates D2 receptors do ——— but higher levels ———–
Small amount of drug that stimulates D2 receptors: much lower locomotion (activated autoreceptors - so reduction in dopamine levels)
Higher amount of the drug: much higher locomotion (activated receptors on postsynaptic neurons, despite low dopamine levels)
Selective knockout of D2 autoreceptors (but not postsynaptic D2) in animals leads to
greater DA-mediated locomotion vs controls - confirming these receptors attenuate DA transmission
DA originates from several cell groups, mostly in midbrain:
A few groups send out very distal broadcasts of dopamine, to their axons
Cell groups A1 to A7 are noradrenergic (a for amine probably)
Cell groups A8 to A16 are dopaminergic
3 key dopamine pathways:
nigrostriatal (A9 axons): nigrostriatal for voluntary movement(can be damaged by neurotoxin 6-OHDA and MPTP), dorsal striatum DA for action selection
A10 (ventral tegmental) has 2 pathways: mesolimbic and mesocortical
mesolimbic: reward and motivational, linked to limbic system (NOT pleasure)
mesocortical: projects to frontal cortex, linked to cognitive functions
DA receptor subtypes:
D1 to D5; all metabotropic; D1 and D5 are simliar, D2,D3 and D4 are similiar
D1 activation stimulates adenylyl cyclase and cAMP synthesis
D2 activation has opposite effect on cAMP
D2 antagonists ——- DA release and ——– postsynaptic DA signaling
D2 antagonists increase DA release (by blocking autoreceptor) but also reduce postsynaptic DA signaling (so net effect is negative)
–receptors have a higher (5x) affinity for dopamine compared to—–
D2 has 5x affinity than D1
heteroreceptors
Some DA receptors are heteroreceptors, on glutamate/GABA terminals that modulate fast transmission presynaptically
E.g. Prefrontal cortical glutamate terminals in striatum contain D2 receptors - their activation attenuates glutamate release
non-selective DA receptor agonist
apomorphine: Stimulates D1 and D2 receptors
Causes behavioural activation similar to that seen with cocaine, amphetamine (move a lot more)
non-selective DA receptor antagonist
flupenthixol blocks both D1-D2 receptors (broad spectral drugs); reduces modivation and produces catalepsy at higher doses
selective DA receptor antagonist
Haloperidol: Highly selective (>1000 times affinity) for D2-like vs D1-like - but - binds to D2, D3, and D4 with similar affinity
Easier to have antagonists that are selective
behavioural supersensitivity experiment
Give D2 antagonist repeatedly over 12 days (e.g. haloperidol-HAL), rats develop behavioural supersensitivity
Initially, HAL blocks effects of DA agonist (like amphetamine - AMPH)
Locomotor actions are modulated by dopamine agonists like amphetamine
After chronic treatment, this dose HAL no longer effective at blocking AMPH effects (some kind of tolerance)
May underlie why some antipsychotics “stop working” over time
THEN - when antagonist treatment stopped - DA agonist (e.g. apomorphine, amphetamine) causes greater (locomotor) response vs. controls
May be caused to increase density of D2 receptors (receptor up-regulation)
norepinepherine anatomy (central)
Central NE neurons cells bodies reside in pons and medulla in brain stem; locus coeruleus (LC) in the pones is a dense collection of NE neurons (A6 cell group)
- it looks blue; it is more spreadout than dopamine; axons extend to nearly all parts of forebrain, also reaches cerebellum and spinal cord
norepinepherine anatomy (peripheral)
SNS uses NE that release from 1.sympathetic noradrenergic neurons at synapse-like contacts; 2. adrenal glands and travel in the bloodstream to target organs (but cannot cross BBB)
adrenergic receptor families
2 main families, both metabotropic: alpha and beta; distributed widely across cortical and subcortical sites